Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Resources, news and special offers to support you and your professional development during this difficult time.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Download your copy of the new events calendar and see all the online workshops, conferences, RAC exams and European online workshops RAPS has planned for 2021 at a glance.
Registration is now open for RAPS Euro Convergence 2021! Attend to join peers from EU and around the world to gain insights and exchange ideas on the regions most pressing issues.
An invaluable resource for any professional engaged in designing, composing, compiling, or commenting on regulatory documentation
From self-assessments to help you identify your strengths and areas to focus on to reference books and online courses that will help you fill in the gaps in your regulatory knowledge, RAPS has the resources to help you prepare for the RAC exam.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Posted 09 August 2016 | By Zachary Brennan
Australia’s Therapeutic Goods Administration (TGA) on Tuesday announced upcoming changes to the way medicine labels on the island will look and be laid out in order to make more pertinent information about medicines easier to find.
The changes, which will be implemented over four years beginning 31 August 2016, will be made available in Australia’s Federal Register of Legislation from 17 August 2016, along with guidance on how to apply the new labeling orders.
The four-year transition period will allow drug sponsors time to adapt to the new requirements, and from 1 September 2020 all new medicine labels will need to meet the new requirements, TGA says.
Since labeling requirements for Australian drugs have not been amended since 2014, the update will further align the labels with international best practice, TGA says.
The main changes include:
“Prescription medicines will also have a designated space for a dispensing label,” TGA explains. “These labels are applied by the pharmacist and include important information like your name and dosage instructions. The defined space for a dispensing label space will help ensure that other information included on a carton or bottle is not covered.” In terms of the regulations, the label requirements have been split into two new labeling orders:
TGA says the split was applied to better consider the different risk levels for prescription and non-prescription medicines and also to improve overall readability.
During the four-year transition period, pharmaceutical sponsors can choose to comply with the old labeling requirements under TGO 69 or the new labeling requirements under TGO 91/92 (whichever applies).
“Labels must fully comply with all requirements of either the old or the relevant new Order. A label cannot selectively comply with parts of multiple Orders,” TGA says.
After the transition period, all medicines must comply with either TGO 91 or TGO 92.
Australia's medicine labels are becoming clearer
Tags: Australia drug labels, drug label, drug labeling changes, dispensing label
Regulatory Focus newsletters
All the biggest regulatory news and happenings.